Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Sanofi ADR (SNY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sanofi ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
45.20 -3.46    -7.11%
10/08 - Closed. Currency in USD ( Disclaimer )
After Hours
45.36
+0.16
+0.35%
0:59:46 - Real-time Data
  • Volume: 9,881,862
  • Bid/Ask: 45.26 / 45.37
  • Day's Range: 43.20 - 46.93
Type:  Equity
Market:  United States
Sanofi ADR 45.20 -3.46 -7.11%

Sanofi reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EUR 10,116 million compared to EUR 8,744 million a year ago. Net income was EUR 1,175 million compared to EUR 1,198 million a year ago. Basic earnings per share from continuing operations was EUR 0.94 compared to EUR 0.96 a year ago.For the six months, sales was EUR 19,790 million compared to EUR 17,335 million a year ago. Net income was EUR 3,184 million compared to EUR 2,764 million a year ago. Basic earnings per share from continuing operations was EUR 2.55 compared to EUR 2.21 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

SNY Income Statement

Gross margin TTM 69.46%
Operating margin TTM 21.86%
Net Profit margin TTM 15.8%
Return on Investment TTM 8.8%
 Total Revenue  Net Income
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Revenue 10742 10053 21244 10829
Gross Profit 7492 7173 14530 7591
Operating Income 2152 2397 4513 3042
Net Income 1175 2009 3447 2317

SNY Balance Sheet

Quick Ratio MRQ 0.67
Current Ratio MRQ 1.3
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 29.93%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Total Assets 121826 120242
Total Liabilities 50522 51561
Total Equity 71304 68681

SNY Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 10522
Cash From Investing Activities -7298
Cash From Financing Activities -7056
Net Change in Cash -3817
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Comments

Write your thoughts about Sanofi ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email